These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3896156)
1. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer]. Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156 [TBL] [Abstract][Full Text] [Related]
2. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma]. Furue H Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154 [TBL] [Abstract][Full Text] [Related]
3. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers]. Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157 [TBL] [Abstract][Full Text] [Related]
4. Phase I evaluation of a synthetic mutant of beta-interferon. Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062 [TBL] [Abstract][Full Text] [Related]
5. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma. Vugrin D; Hood L; Laszlo J J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma. Chaplinski T; Laszlo J; Moore J; Silverman P Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552 [TBL] [Abstract][Full Text] [Related]
7. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients]. Yoshimoto J; Tsushima T; Matsumura Y; Ohmori H; Saito N; Tanaka H; Asahi T; Ohkita K; Tanahashi T; Nanba K Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282 [TBL] [Abstract][Full Text] [Related]
8. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon]. Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077 [TBL] [Abstract][Full Text] [Related]
9. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies]. Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of weekly high-dose human lymphoblastoid interferon. Connors JM; Silver HK Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449 [TBL] [Abstract][Full Text] [Related]
11. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor]. Furue H Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861 [TBL] [Abstract][Full Text] [Related]
12. Phase I study of human leukocyte interferon in patients with advanced cancer. Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of recombinant beta interferon in advanced colorectal cancer. Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies. Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323 [TBL] [Abstract][Full Text] [Related]
15. Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer. Caballero M; Grau JJ; Blanch JL; Domingo-Domenech J; Auge JM; Jimenez W; Bernal-Sprekelsen M Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1143-8. PubMed ID: 18025320 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma. Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study. Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340 [TBL] [Abstract][Full Text] [Related]
19. [Interferons--its method of administration and adverse effect related to pharmacokinetics ]. Furue H Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804 [TBL] [Abstract][Full Text] [Related]
20. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer]. Sugiyama M; Morisaki N; Konishi K; Go K; Sugita M; Nakai Y Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]